I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Cosaert, J.
126
results:
Search for persons
X
Format
Online (124)
Print (2)
Mediatypes
E-Books (1)
Articles (Online) (68)
Articles (Print) (2)
OpenAccess-fulltext (55)
Languages
english (111)
french (3)
Sorted by: Relevance
Sorted by: Year
?
1
109O Phase I study of MEDI9253, a recombinant Newcastle Dis..:
Postel-Vinay, S.
;
Cosaert, J.
;
Hattersley, M.
...
ESMO Open. 8 (2023) 1 - p. 101161 , 2023
Link:
https://doi.org/10.1016/..
?
2
OA15.05 HUDSON: An Open-Label, Multi-Drug, Biomarker-Direct..:
Besse, B.
;
Awad, M.M.
;
Forde, P.M.
...
Journal of Thoracic Oncology. 17 (2022) 9 - p. S41-S42 , 2022
Link:
https://doi.org/10.1016/..
?
3
160P COLUMBIA-1: A phase Ib/II, open-label, randomized, mul..:
Segal, N.H.
;
Tie, J.
;
Kopetz, S.
...
Immuno-Oncology and Technology. 16 (2022) - p. 100272 , 2022
Link:
https://doi.org/10.1016/..
?
4
SCLC subtype-enriched biomarkers define positioning of Auro..:
Della Corte, C.
;
Gay, C.
;
Urosevic, J.
...
European Journal of Cancer. 138 (2020) - p. S47 , 2020
Link:
https://doi.org/10.1016/..
?
5
Safety, tolerability, and pharmacokinetics of single and mu..:
Higano, C. S.
;
Berlin, J.
;
Gordon, M.
...
Investigational New Drugs. 33 (2015) 2 - p. 450-462 , 2015
Link:
https://doi.org/10.1007/..
?
6
Evaluation of accuracy of fine needle aspiration cytology i..:
Engohan‐Aloghe, C.
;
Hottat, N.
;
Cosaert, J.
...
Cytopathology. 21 (2010) 3 - p. 161-163 , 2010
Link:
https://doi.org/10.1111/..
?
7
Review of Pulmonary Hemorrhage (PH) in Non–Small-Cell Lung ..:
LaFleur, F.
;
Skillings, J.
;
Hirsh, V.
...
Clinical Lung Cancer. 8 (2007) 7 - p. 447 , 2007
Link:
https://doi.org/10.1016/..
?
8
6526 POSTER Review of pulmonary haemorrhage (PH) in non-sma..:
Hirsh, V.
;
Bennouna, J.
;
Kuo, H.
...
European Journal of Cancer Supplements. 5 (2007) 4 - p. 365 , 2007
Link:
https://doi.org/10.1016/..
?
9
6610 POSTER Safety of bevacizumab treatment in non-small ce..:
Leighl, N.
;
Bennouna, J.
;
Kuo, H.
...
European Journal of Cancer Supplements. 5 (2007) 4 - p. 391 , 2007
Link:
https://doi.org/10.1016/..
?
10
Safety of Bevacizumab Treatment in Non–Small-Cell Lung Canc..:
Skillings, J.
;
LaFleur, F.
;
Leighl, N.
...
Clinical Lung Cancer. 8 (2007) 7 - p. 454 , 2007
Link:
https://doi.org/10.1016/..
?
11
Current phase II data for ZD0473 in patients with mesotheli..:
Giaccone, G.
;
O'Brien, M.
;
Byrne, M.
..
European Journal of Cancer. 37 (2001) - p. S45 , 2001
Link:
https://doi.org/10.1016/..
?
12
Phase I trial of ZD0473 in combination with vinorelbine for..:
Douillard, J.
;
Cosaert, J.
;
Barbarot, V.
European Journal of Cancer. 37 (2001) - p. S77 , 2001
Link:
https://doi.org/10.1016/..
?
13
A phase I dose-escalation study of zd0473 combined with pac..:
Gatzemeier, U.
;
Twelves, C.
;
Anthoney, D.A.
...
European Journal of Cancer. 37 (2001) - p. S74-S75 , 2001
Link:
https://doi.org/10.1016/..
?
14
ZD0473 phase II monotherapy trial in second-line ovarian ca..:
Gore, M.
;
Atkinson, R.J.
;
Dirix, L.
...
European Journal of Cancer. 37 (2001) - p. S261 , 2001
Link:
https://doi.org/10.1016/..
?
15
An open-label, dose-escalation study of ZD0473 combined wit..:
Gatzemeier, U
;
Kaye, S.B
;
Groth, G
..
Lung Cancer. 29 (2000) 1 - p. 70-71 , 2000
Link:
https://doi.org/10.1016/..
1-15